Last updated at 03 Jul 2024 05:14 AM
Director
DIN: 08367656
Ritaben Nileshbhai Kikani is currently associated with 2 companies in various capacities such as Director and Designated Partner. They serve as a Director at INDO US BIO-TECH LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 08367656.Ritaben Nileshbhai Kikani has previously been associated with 1 company in roles such as Additional Director.Ritaben Nileshbhai Kikani is currently involved in 2 different roles. Their most recent position is with KAVYANSH PACK LLP as a Designated Partner. The first company Ritaben Nileshbhai Kikani was appointed to as a director was INDO US BIO-TECH LIMITED. Ritaben Nileshbhai Kikani is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Ritaben Nileshbhai Kikani is currently associated with 2 companies in various capacities such as Director and Designated Partner. They serve as a Director at INDO US BIO-TECH LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 08367656.Ritaben Nileshbhai Kikani has previously been associated with 1 company in roles such as Additional Director.Ritaben Nileshbhai Kikani is currently involved in 2 different roles. Their most recent position is with KAVYANSH PACK LLP as a Designated Partner. The first company Ritaben Nileshbhai Kikani was appointed to as a director was INDO US BIO-TECH LIMITED. Ritaben Nileshbhai Kikani is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
2
Female
India
Gain instant access to verified contact details.
Current Companies (1)
Current LLPs (1)
Past Companies (1)
1y 5m 9 Months Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| INDO US BIO-TECH LIMITED | Director | 28-Sep-2019 |